POCT which is Point-of-care testing is crucial for the fast detection of analytes near to the patient, which promotes better disease diagnosis, observation, and management. It equips us with quick medical decisions, as the condition can be diagnosed at a very early stage, leading to improved health outcomes for patients by enabling the early start of treatment.
According to the research reports, ‘Point-of-Care Diagnostics Market By Products (Infectious Disease Testing, Glucose Monitoring, Hematology Testing, Pregnancy and Fertility Testing, Urinalysis Testing, Cardio metabolic Monitoring, Tumors or Cancer Marker Testing, Coagulation Monitoring, Cholesterol Testing, Drugs of Abuse Testing), Prescription Mode (Prescription-based Point-of-Care Diagnostics, Over-the-Counter-based Point-of-Care Diagnostics), End-users (Hospitals, Clinics/Physician Office Laboratory, Home Care, Ambulatory Care), and Regions (North America, Europe, Asia Pacific, Rest of the World): Global Forecast up to 2025’ states that Abbott Laboratories, Hoffmann-La Roche Ltd., Johnson & Johnson, Danaher Corporation, Siemens Healthineers Inc. (Siemens AG), Trinity Biotech plc, Qiagen N.V. , OraSure Technologies Inc., Instrumentation Laboratory (IL), Becton Dickinson and Company, Nova Biomedical and many others are some of the significant players which are currently in a leading position of the market. The research report also covers extensive profiling of each company mentioned above based on some parameters such as company performance, recent developments, product and service offerings, revenue, regional presence, collaborative business strategies, and a lot more. According to the report, there are so many companies leading in the industry, that one can only imagine the competition of being the best.
The global Point-of-care Diagnostics market is further classified into segments as already stated in the title of the report. Specifically, in the region segment, North America is responsible for the largest share of the global market in 2018, and in Asia Pacific regions the market is expected to expand at a high CAGR during the forecast period. Whereas, in the product segment, Glucose monitoring kits accounted to have a significant market share in 2018, causing an increase in the predominance of diabetes, lifestyle change, a growing elderly population, and rising demand for disease management. The infectious disease testing segment is also expected to increase at a high CAGR during the review period 2019-2025. Likewise, the report analyses the forecast of all other segments individually.
Request For Sample Report @ https://www.kenresearch.com/sample-report.php?Frmdetails=NDc2NjE2
Moreover, the study also discusses various qualitative and quantitative information that includes market dynamics, historical and forecast market data, supply and demand details, growth drivers, development of the market, application details, price trends (present and future), restraints, company shares of the leading players mentioned above and detailed analysis of data and much more. The report mentions several other information such as investments made by stakeholders, player initiatives, and government initiatives toward the diagnostics segment in the upcoming years along with details of the new companies entering the market.
The point-of-care diagnostic market is expected to grow and offers a great opportunity for the industry players. It is expected to reach a substantial value in terms of revenue of USD million by the end of the year 2025. This will take place at a double-digit CAGR during the forecast period of 2020-2025. The technology advancements and the launch of new products have fuelled the adoption of point-of-care diagnostics products and hence increases the market.
For More Information, Click on the Link Below:-
Global Point of Care Diagnostics Market: Ken Research
Related Reports:-
Point-of-Care Diagnostics Market 2018-2024
Follow Us
LinkedIn | Instagram | Facebook | Twitter | YouTube
Contact Us:-
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-9015378249